|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 90 No. 5 (September 1), 1997:
pp. 1799-1806
Defects in Yolk Sac Hematopoiesis in Mll-Null Embryos
By
Jay L. Hess,
Benjamin D. Yu,
Bin Li,
Rob Hanson, and
Stanley J. Korsmeyer
From the Howard Hughes Medical Institute, the Division of Molecular Oncology, the Departments of Medicine and Pathology, Washington University School of Medicine, St Louis, MO.
 |
ABSTRACT |
Translocations involving the mixed lineage leukemia gene (MLL ), the human homolog of the Drosophila gene trithorax, are one of the most common genetic alterations in human acute leukemias. Each translocation involving MLL results in loss of one functional copy of MLL and the generation of a chimeric fusion protein with potential dominant negative or neomorphic activity. Mll is a positive regulator of Hox genes, which have been implicated in both axial skeleton patterning and hematopoietic development. Previous studies indicated that Hox gene expression is altered in Mll heterozygous (+/-) and homozygous (-/-) deficient mice. To study the role of Mll in hematopoiesis and to obtain insights into leukemogenesis, we have examined the effects of haplo-insufficiency or absence of Mll by in vitro differentiation of Mll +/+, +/-, and -/- yolk sac progenitor cells. Mll -/- colonies were fewer in number, took longer to develop, and contained fewer cells than their wild-type and heterozygous counterparts. Formation of colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte (CFU-GEMM), colony-forming unit-macrophage (CFU-M), and burst-forming unit-erythroid (BFU-E) was markedly decreased in Mll -/- cultures, while numbers of colony-forming unit-erythroid (CFU-E), colony-forming unit-granulocyte (CFU-G), and colony-forming unit-granulocyte macrophage (CFU-GM) were essentially unaffected. Despite the decreased numbers of colonies present, Mll -/- cultures showed all cell types without morphologic evidence of maturation arrest. These studies indicate that Mll is required for normal numbers of hematopoietic progenitors and their proper differentiation, especially along the myeloid and macrophage pathways.
| |
INTRODUCTION |
REARRANGEMENTS of the mixed lineage leukemia gene (MLL ) are associated with both acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML). The most common alterations of MLL are the t(4; 11) and t(11; 19) translocations that are present in 7% to 10% of ALL and more than 70% of acute leukemias in infants. Infants with translocations involving the 11q23 locus have a markedly worse survival than those with germline 11q23.1,2 The leukemic blasts in infant ALL usually express the B-cell marker CD19, as well as HLA-DR and TdT, but are often common acute lymphoblastic leukemia antigen (CALLA) and cytoplasmic immunoglobulin negative (early precursor B-ALL). In addition, the cells usually express the myelomonocytic marker CD15. The mixed lineage of these blasts has led to speculation that the MLL-AF4 protein that is formed by the t(4; 11) translocation, and other MLL fusion proteins, transforms a multipotential stem cell or disturbs differentive cell fate. This concept is further supported by the finding that MLL rearrangements are one of the common genetic alterations in acute myelogenous leukemia.3 In all, more than 20 different translocation partners have been identified, which are predominantly associated with either lymphoid or myeloid leukemias.
Sequence analysis of MLL shows homology to the Drosophila gene trithorax (trx ) in three regions including two putative zinc finger domains and a highly homologous carboxyl terminus that shows 60% identity with trx over a 220 amino acid region.4-7 Trithorax positively regulates Hox gene expression in that Drosophila trx mutants show loss or abnormal patterns of Hox gene expression that result in defects in segment identity.8,9 Analysis of Mll null mice generated in our laboratory indicates that Mll functions like trx to positively regulate Hox gene expression. The ability of Mll to regulate Hox gene expression suggests that its role in both hematopoiesis and leukemogenesis may be mediated by altering patterns of Hox gene expression. A rapidly expanding body of literature shows that specific groups of Hox genes are expressed in specific hematopoietic lineages.10 Hox genes in the 3' end of the cluster tend to be expressed in hematopoietic progenitors, while expression of the more 5' genes persists in more differentiated cells.11 Altered expression of specific Hox genes by gene targeting or antisense oligonucleotides has been shown to inhibit differentiation along specific lineages. For example, increased expression of Hox2B has been shown to inhibit erythroid differentiation.12 Increased expression of specific Hox genes has also been implicated in both murine and human leukemias. Overexpression of Hox a7 and Hox a9 by proviral integration appears to play an etiologic role in myeloid leukemias in BXH-2 mice.13 Remarkably, the t(7; 11)(p15; p15) translocation found in some human acute myeloid leukemias has been shown to result in fusion of the HOXA9 gene to the nucleoporin NU98.14,15 Given the apparent importance of Hox genes in controlling hematopoiesis, it seemed likely that deficiency of MLL, a known regulator of Hox genes, would result in disordered hematopoiesis. Furthermore, analysis of hematopoiesis in Mll null embryos might yield important clues to the mechanism of Mll-mediated leukemogenesis.
In this study, we show that Mll is expressed in T and B lymphocytes and in myeloid cells, but is not expressed in mature erythroid cells. Analysis of yolk sac hematopoiesis from Mll +/+, +/-, and -/- mice16 showed marked differences in the kinetics of colony formation and in the size of hematopoietic colonies obtained. The number and size of myeloid (CFU-M, CFU-GM) and mixed (CFU-GEMM) colonies was markedly decreased, and the number of BFU-E was moderately decreased in Mll null embryos. Histologic examination of in vitro cultures showed identical cell types present in Mll +/+, +/-, and -/- colonies, with no evidence of a maturation block. These data suggest that Mll affects early events in hematopoiesis such as hematopoietic progenitor proliferation or recruitment, but is not required for the terminal stages of hematopoietic differentiation.
| |
MATERIALS AND METHODS |
Cytochemical and flow cytometric analysis of Mll expression.
Air dried bone marrow smears from Mll +/+ and +/- mice were fixed for 10 minutes in phosphate-buffered saline/2% neutral buffered formalin and were then stained overnight at 37°C for  -galactosidase activity in the presence of NP-40 and sodium deoxycholate.17 -Galactosidase activity in bone marrow and spleen cells was analyzed using flow cytometric detection of fluorescein di--D-galactopyranoside (FDG) (Sigma, St Louis, MO). Single cell suspensions (150 µL) in hypotonic buffer were stained for 10 minutes at 37°C with an equal volume 2 mmol/L FDG dissolved in FDG solvent (eight parts H2O: 1 part dimethyl sulfoxide: one part ethanol). The FDG-loaded cells were then stained with either biotinylated (Gr-1, CD3) or phycoerythrin-conjugated (Ter-119, CD11b, B220) monoclonal antibodies (Pharmingen, San Diego, CA) and were then analyzed using a FACscan flow cytometer (Becton Dickinson, San Jose, CA).
RNA in situ hybridization analysis.
In situ hybridization on paraformaldehyde-fixed spleen sections was performed as previously described16 using an antisense Mll probe riboprobe generated from an EcoRI-Xba I cDNA subclone that was linearized with EcoRI and transcribed using T7 RNA polymerase (Boehringer Mannheim, Indianapolis, IN) and 33P-uridine 5'-triphosphate (Amersham, Arlington Heights, IL). Sense probes were generated by linearizing the same template with Xba I and transcribing with T3 RNA polymerase (Boehringer Mannheim).
Analysis of yolk sac hematopoiesis.
Yolk sacs from E10.5 embryos were dissected and were then incubated in 0.1% collagenase/phosphate-buffered saline/20% fetal bovine serum for 30 minutes. Following incubation, the yolk sacs were dispersed by aspiration through 25 and then 30 gauge hypodermic needles and were then plated in methylcellulose media containing recombinant growth factors (Stem Cell Technologies, Inc, Vancouver, BC, Canada). Cells from each yolk sac were plated in duplicate in 2 mL of methylcellulose media (alpha MEM/0.9% methylcellulose/10 µg/mL bovine pancreatic insulin/200 µg/mL human transferrin/2 mmol/L glutamine/10 ng/mL recombinant murine interleukin-3 [IL-3]/10 ng/mL recombinant human IL-6/50 ng/mL stem cell factor/15% fetal bovine serum) with or without added erythropoietin (30/mL). For quantitation of colony-forming unit-erythroid (CFU-E), dissociated cells representing one half of a yolk sac were plated in 2 mL methylcellulose media containing 3 U/mL recombinant erythropoietin and without added insulin, transferrin, or recombinant growth factors. For quantitation of colony-forming unit-granulocyte, erythroid, monocyte, megakaryocyte (CFU-GEMM), colony-forming unit-granulocyte macrophage (CFU-GM), colony-forming unit-granulocyte (CFU-G), and colony-forming unit-macrophage (CFU-M), one half of the cells from each dissociated yolk sac were plated in methylcellulose media containing insulin, transferrin, and recombinant IL-3, IL-6, and stem cell factor, either with or without added erythropoietin. Colonies were scored according to published criteria for human cells.18 CFU-E were scored after 3 days in culture, while the other colony types were scored after 7 days in culture. The morphology of colonies and of bulk cultures was examined by diluting the aspirated colony or dish in phosphate-buffered saline, washing the cells and then preparing cytospin and smear preparations that were then Wright-Giemsa stained. The number of cells in individual colonies was determined by aspirating individual colonies, diluting in known volumes of phosphate-buffered saline, and then counting cell numbers by trypan blue exclusion using a hemocytometer. Embryos corresponding to each yolk sac were genotyped by polymerase chain reaction (PCR) analysis of DNA prepared from the tail of each embryo by PCR using the primer set ST2B+ (5'-GAACAGCAGATTCAGCGCCACG-3') and ST2B-(5'-GGACGCTCCAGAAGAAG TTCGATTA-3'), which flanks the third exon of Mll and generates an 840-bp PCR product for the wild-type allele and the primer set ST2B+ and ST2lacZ-(5'-GAACAAACGGCGG ATTGACCGTAATG-3'), which generates a 504-bp PCR product in the targeted Mll allele.
Flow cytometric analysis of cell surface marker expression.
Thirteen-day yolk sac methylcellulose cultures were diluted and washed with phosphate-buffered saline and were stained with phycoerythrin-conjugated monoclonal antibodies (CD11b, c-kit) (Pharmingen) and were then analyzed by flow cytometry as described above.
Reverse transcriptase (RT)-PCR analysis of yolk sac cultures.
Yolk sac cultures grown in methycellulose media containing IL-3, IL-6, stem cell factor and erythropoietin (b) were harvested after 7 days and RNA was prepared using RNeasy (Qiagen Inc, Chatsworth CA). cDNA was synthesized from 1.25 × 105 cell equivalents of RNA using 500 U SuperScript II RT (GIBCO-BRL, Gaithersburg MD) in a volume of 50 µL first-strand synthesis buffer (50 mmol/L TRIS pH 8.3/75 mmol/L KCl/3 mmol/L MgCl2 /10 mmol/L dithiothreitol (DTT)/200 µg/mL random hexamers/0.125 mmol/L deoxyribonucleoside triphosphates/4,000 U/mL RNAse inhibitor (Promega Corp, Madison WI). Reactions were incubated at 25°C for 10 minutes, 42°C for 60 minutes, 70°C for 15 minutes, and 4°C for 5 minutes. A total of 25 µL of cDNA was used for each PCR reaction. Reactions were done using 2.5 U Amplitaq polymerase (Roche Molecular Systems Inc, Branchberg NJ) in a volume of 40 µL (10 mmol/L TRIS pH 8.3/50 mmol/L KCl/1.5 mmol/L MgCl2 /0.001% gelatin/0.125 mmol/L dNTPs/0.06% dimethyl sulfoxide (DMSO)/500 ng each of 5' and 3' primers). Reactions were run for 35 or 40 cycles with a melt temperature of 94° × 1 minute, annealing temperature of either 55°C or 58°C × 1 minute, and extension temperature of 72°C × 1.5 minutes.
PCR primers and product sizes were: CD34 (237 bp),19,20 GATA-2 (720 bp),21 GM-CSF-R (598 bp),22 M-CSF-R (448 bp),23 CD11b (622 bp),22 CD18 (426 bp),22 CD64 (510 bp),22  -globin (331 bp),24 -major-globin (578 bp),21 and -actin (568 bp).25  y globin primers (5'-GACAGCTTTGGGAACTTGTCC-3' forward, 5'-TCAGCTGTGAATTCATTGCCG-3' reverse were a gift from Tim Ley (Division of Stem Cell Biology, Washington University School of Medicine, St Louis, MO). The intensity of the -actin PCR product was comparable for each sample.
| |
RESULTS |
Patterns of Mll expression in hematopoietic cells.
Mll +/- mice are mildly anemic and thrombocytopenic, although their red and white blood cell morphology appears to be normal.16 In addition, flow cytometric analysis showed mildly decreased numbers of B lymphocytes in heterozygous animals. Heterozygous mice were analyzed to determine the normal expression pattern of Mll in hematopoietic cells. The targeting vector used to disrupt Mll introduced lacZ in frame with Mll so that lacZ expression provides a convenient way of measuring levels of Mll expression. Flow cytometric detection of the fluorescent -galactosidase substrate FDG showed that Mll was expressed in the majority of thymocytes (CD3 positive) (Fig 1). Mll was also expressed in the majority of B lymphocytes in bone marrow and in spleen (Figs 1 and 2). In addition, flow cytometric analysis of bone marrow showed that Mll was expressed in maturing myeloid or monocytic cells (Gr-1 and CD11b positive), but not in late erythroid cells (Ter 119 positive) (Fig 2). Air-dried bone marrow smears stained with X-Gal and counterstained with eosin showed intense staining of megakaryocytes and myeloid cells, with the strongest staining seen in neutrophils (Fig 3). -Galactosidase staining of small intestine showed intense staining of lymphoid follicles within Peyer's patches (data not shown). In situ hybridization analysis of tissue sections of spleen confirmed that Mll is expressed at high levels in the lymphocytes of the white pulp with a pattern of expression that appears to be highest in germinal centers (Fig 4).
View larger version (48K):
[in this window]
[in a new window]
| Fig 1.
Flow cytometric analysis of -galactosidase expression in thymocytes and splenocytes. Mll is expressed in both CD3low and CD3high thymocytes. A small population of CD3 high thymocytes was -galactosidase negative. Most B220 positive cells expressed Mll and the majority of IgM positive cells expressed Mll.
|
|
View larger version (45K):
[in this window]
[in a new window]
| Fig 2.
Flow cytometric analysis of -galactosidase expression in bone marrow. Mll is expressed in B lymphocytes (B220 positive), and myeloid cells (Gr-1 and CD11b positive), but is not expressed in erythroid cells (Ter 119 positive).
|
|
View larger version (141K):
[in this window]
[in a new window]
| Fig 3.
Cytochemical staining for galactosidase in bone marrow smear from an 8-week-old Mll +/- mouse. A megakaryocyte and several neutrophils are strongly positive. No staining was seen in wild-type marrow (original magnification × 810).
|
|
View larger version (151K):
[in this window]
[in a new window]
| Fig 4.
In situ hybridization analysis of Mll expression in spleen. RNA in situ hybridization was performed on cryostat sections of paraformaldehyde-fixed spleen as described in Materials and Methods. High level Mll expression is confined to the splenic white pulp (original magnification × 21).
|
|
In contrast to heterozygous mice, Mll null mice were embryonic lethal and showed severe developmental abnormalities including branchial arch and neuronal defects (B.D.Y. and S.J.K., manuscript in preparation). Viable embryos could be recovered up to E10.5. Histologic sections of the Mll null embryos showed abundant erythropoiesis, with pooling of erythroid cells in the coelomic cavity. No intracranial hemorrhages suggestive of thrombocytopenia were observed. Touch preparations of cord blood in -/- embryos showed predominantly nucleated red blood cells and platelets.
Analysis of Mll yolk sac hematopoiesis.
The early lethality of Mll null embryos at about E11 precedes the time at which the predominant site of hematopoiesis shifts from yolk sac to liver (E11.5-E12.5). At E10.5, liver primordia undergoing extensive karyorrhexis could be identified in -/- embryos, which were too poorly preserved to assess hematopoietic function. Therefore, colony assays were performed on dissociated yolk sacs to study the role of Mll in hematopoiesis. Yolk sacs dissected from E10.5 embryos from +/- × +/- matings were dissociated and plated in methylcellulose media containing recombinant growth factors to support both erythroid and myeloid differentiation. Under these conditions, the colonies formed are of definitive hematopoieticorigin.26 In these preliminary experiments, several differences were noted between hematopoiesis in the -/- yolk sac cultures and in the +/+ cultures. First, the total number of colonies formed was decreased by more than 75% compared with +/+ cells. This decrease was due in part to a decreased number of cells in -/- yolk sacs (1.2 × 105 ± 4.4 × 104 cells in +/+ [n = 5] compared with 5.1 × 104 ± 3.2 × 104 in -/- [n = 3]), however the number of colonies obtained was decreased a further 30% when normalized to the number of cells plated. Secondly, the -/- colonies were smaller than wild-type colonies. For example, after 4 to 5 days in culture, macroscopically visible colonies were present in +/+ and +/- cultures, but were absent from the -/- cultures. The macroscopically visible colonies that eventually formed in -/- cultures were smaller and were less cohesive than in the +/+ and +/- cultures (Fig 5). From these preliminary experiments, it appeared that committed erythroid progenitors (cells corresponding to CFU-E that gave rise to hemoglobinized colonies at 3 days in culture) were largely unaffected in Mll -/- yolk sacs, whereas the number of myeloid (ie, nonhemoglobinized colonies) was markedly decreased.
View larger version (100K):
[in this window]
[in a new window]
| Fig 5.
E10.5 Yolk sac hematopoiesis. (A and B) Dark-field illumination of Mll +/+ (A) or Mll -/- (B) colonies from dissociated yolk sacs cultured for 9 days in methylcellulose media containing IL3, IL-6, and stem cell factor (original magnification × 3.7). (C and D) Colonies with CFU-E morphology in Mll +/+ (C) or Mll -/- (D) cultures grown for 5 days in methylcellulose media containing recombinant erythropoietin (original magnification × 134). (E and F ) Colonies with CFU-GM morphology in Mll +/+ (E) or Mll -/- (F ) cultures grown for 5 days in methylcellulose media containing recombinant IL3, IL6, and stem cell factor. The Mll -/- colony is small and poorly formed (original magnification × 67). (G and H) Maturing myeloid elements and macrophages in Wright-Giemsa-stained smear preparations from Mll +/+ (G) and Mll -/- (H) cultures after 10 days in culture (original magnification × 810).
|
|
To further investigate these differences, the number of CFU-E was determined by plating dissociated yolk sacs in media containing only erythropoietin as an added growth factor, while the number of CFU-GEMM, CFU-GM, CFU-G, and CFU-M was determined by plating in methylcellulose media containing insulin, IL-3, IL-6, and stem cell factor with or without erythropoietin as added growth factors. The number of CFU-E was comparable in -/-, +/- and +/+ cultures (Table 1). In contrast, a moderate decrease in the number of BFU-E and marked decreases were seen in the number of colonies with CFU-GEMM and CFU-M morphology were seen in the -/- cultures. Marked decreases in the number of CFU-GEMM and CFU-M were also seen in "complete" media containing erythropoietin (Table 1B). The number of cells per colony was decreased more than 60% in the -/- cultures. The mean number of cells per colony in media containing IL-3, IL-6, and stem cell factor was 4.9 × 103 (±5.3 × 103) cells for -/- compared with 1.3 × 104 (±1.0 × 104) for +/+ and 1.3 × 104 (±9.9 × 103) for +/- colonies. Histologic examination of cytospin and smear preparations from the +/+, +/-, and -/- yolk sac cultures showed maturing myeloid elements, erythroid elements including occasional anucleated red blood cells, and rare megakaryocytes in cultures from all genotypes. Differential counts performed on Wright-Giemsa stained smears showed similar proportions of cell types, except for a striking decrease in the number of monocytes and macrophages in the Mll -/- cultures (Table 2). Large phagocytic macrophages were notably rare in the -/- cultures.
Only a slight increase in the number of cells with blast or promyelocyte morphology was detected in the Mll -/- cultures. Analysis of cell surface marker expression by flow cytometry showed that the majority of cells in -/- cultures were c-kit positive compared with a minority of cells in the +/+ or +/- cultures (Fig 6). As suggested by the colony counts on cultures grown in media containing IL-3, IL-6, and stem cell factor, the number of mature granulocytes and macrophages was markedly decreased as assessed by the myeloid/macrophage marker CD11b. Expression of additional lineage specific primers was examined by RT-PCR. Expression of early progenitor markers such as CD34 and GATA-2 was unaffected (Fig 7). Adult-type globins (-globin and -major globin) were expressed in -/- cultures providing evidence that their colonies were capable of definitive erythropoiesis. The most consistent abnormality detected by RT-PCR in -/- cultures was decreased expression of M-CSF-R and slightly decreased expression of CD64.
View larger version (15K):
[in this window]
[in a new window]
| Fig 6.
Flow cytometric analysis of yolk sac colonies cultured for 13 days in methylcellulose media containing IL-3, IL-6, and stem cell factor (bold solid line +/+, thin solid line +/-, dotted line -/-). Expression of CD11b (granulocytes, macrophages) is seen in Mll +/+ and +/- colonies, while high-level expression of c-kit (hematopoietic progenitor cells) is seen in Mll -/- cultures. Identical results were obtained in two experiments.
|
|
View larger version (22K):
[in this window]
[in a new window]
| Fig 7.
RT-PCR analysis of yolk sac colonies cultured for 7 days in methylcellulose media containing IL-3, IL-6, stem cell factor, and GM-CSF (top) or IL3-, IL-6, stem cell factor, and erythropoietin (bottom). B.M., control PCR reaction performed on adult murine bone marrow cDNA. The control reaction for globin was performed on E10.5 embryo cDNA.
|
|
| |
DISCUSSION |
We have analyzed yolk sac hematopoiesis in gene ablated mice to study the normal role of Mll in hematopoiesis and to gain insights into the mechanism of Mll-mediated leukemogenesis.
Loss of one functional copy of Mll resulted in hematopoietic defects in yolk sac cultures. The number of BFU-E, CFU-GEMM, and CFU-M was significantly decreased in +/- cultures compared with wild-type cultures, while the number of CFU-E was mildly increased. Similar decreases in colonies with CFU-GM, CFU-M, and CFU-GEMM morphology and unaffected or increased numbers of CFU-E were seen in cultures of Mll +/- bone marrow (data not shown). The apparently normal production of CFU-E is somewhat surprising given that Mll +/- mice are mildly anemic. Although these colonies appeared to be morphologically normal, the possibility remains that they possess functional defects. The observation of Corral et al27 that Mll +/- embryonic stem (ES) cells contribute very little to circulating peripheral blood cells in chimeric animals lends further support to the thesis that two functional copies of Mll are needed for normal hematopoietic progenitor proliferation, survival, or differentiation.
Elimination of both copies of Mll resulted in an even greater reduction in the number of hematopoietic colonies, slower colony growth, and smaller numbers of cells per colony. The number of macrophages was strikingly reduced in -/- cultures, and in keeping with this finding the expression of CD11b by flow cytometry and M-CSF-R by RT-PCR was notably decreased. In contrast, erythropoiesis was relatively unaffected in Mll -/- cells. The CFU-E, BFU-E, and rare CFU-GEMM colonies that formed were morphologically normal in -/- cultures, and like the +/+ and +/- cultures showed adult type (definitive) erythropoiesis as evidenced by the expression of -globin and -major globin (Fig 7).
Our results differ somewhat from the findings of Fidanza et al28 who used a different approach with ES cells assessed in a two-step dissociated embryoid body assay. They report that Mll null ES cells form more colonies with accelerated kinetics. Embryoid body culture experiments appear to closely parallel hematopoiesis in the yolk sac and early fetal liver,29 but can vary in the degree differentiation depending on many experimental variables, especially the specific ES cells and lots of serum used. These experiments of Fidanza et al were done in media containing either no growth factors or flt-3 and stem cell factor. Addition of the latter resulted in a twofold difference in colony number without a change in colony phenotype. In our experiments, we did not observe spontaneous formation of colonies other than CFU-E in media containing only erythropoietin when actual hematopoietic progenitors from Mll -/- yolk sacs were assessed. Although the number of yolk sac progenitors might be decreased as a result of harvesting from a preterminal embryo, the differences persisted when colony numbers were normalized to the number of viable cells plated. In addition, plated cells showed similar viabilities (80% to 100%) from all genotypes of yolk sacs.
The small size and slower growth rate of Mll null yolk sac colonies suggests that Mll is required for normal proliferation and/or survival of hematopoietic progenitors. In addition, the colonies in Mll null cultures were poorly cohesive, raising the possibility of deficient expression of one or more cell surface adhesion molecules needed for normal colony formation. While in vitro cultured fetal cells may not have acquired additional genetic hits required for leukemogenesis, these findings place restraints on the possible mechanisms of oncogenesis. Mll null cells argue against a simple model in which Mll functions as a tumor suppressor in that loss of both functional copies of Mll did not lead to deregulated cell growth. These data also make it unlikely that the chimeric Mll fusion proteins transform via a simple dominant negative mechanism.
Analysis of Mll -/- cultures showed increased expression of the hematopoietic progenitor receptor c-kit in Mll -/- cultures with an accompanying decrease in expression of CD11b. Prominent c-kit expression was also noted on dissociated cells from Mll null embryoid bodies.28 Interestingly, increased c-kit expression was also seen in cultures of Mll +/- compared with +/+ bone marrow (data not shown). c-kit is normally expressed on hematopoietic progenitors including those that give rise to CFU-GEMM, CFU-GM, CFU-M, as well as BFU-E and CFU-E and is downregulated as these cells differentiate.30-35 Expression of c-kit in myeloid cells is normally limited to myeloblasts and promyelocytes.36 The marked increase in c-kit expression in Mll -/- cultures was somewhat surprising given that morphologically only a slight increase in immature myeloid cells was seen. Alternatively, Mll-deficient cells may require the retention of c-kit for their survival. Whether this abnormal c-kit expression pattern has any relationship to leukemogenesis remains to be explored.
The abnormalities seen in Mll -/- yolk sac cultures differ dramatically from what has been reported for targeted disruption of other genes that are important for hematopoietic differentiation, many of which are transcription factors.37,38 Knock-out of the basic helix-loop-helix (bHLH) protein tal-1/SCL, which like MLL is rearranged in leukemias that can differentiate along both lymphoid and myeloid lineages, results in complete absence of both erythropoiesis and myelopoiesis in the yolk sac and in absence of all hematopoietic cell lines in chimeric embryos.39-41 Similarly, knockout of the Lim-domain protein rbtn2/Ttg 2, which is translocated in some human T-cell acute lymphoblastic leukemias and has been shown to complex with tal-1/SCL, also results in complete absence of yolk sac erythropoiesis.42 Homozygous disruption of GATA-2 results in a phenotype that shares some similarities with Mll -/- mice.43 The number of colonies obtained in yolk sac hematopoiesis experiments from GATA-2 -/- cells is markedly decreased compared with heterozygous and wild-type cultures, however, the morphology of the cells obtained is apparently normal.43 GATA-2 knockout embryos differ from Mll knockout embryos in that at the time of death the GATA-2 embryos are markedly anemic, and in general, the defect in yolk sac hematopoiesis is much more severe. The early lethality of Mll embryos precludes assessment of the role of Mll in fetal liver or adult bone marrow hematopoiesis, and the role of Mll in lymphopoiesis. Studies of chimeric mice may shed light on the role of Mll in these later stages of hematopoiesis.
| |
FOOTNOTES |
Submitted December 2, 1996;
accepted April 20, 1997.
Supported by the Parker-Hughes Trust (Los Angeles, CA). B.D.Y. was supported by a training grant from the National Institutes of Health.
J.L.H. and B.D.Y. contributed equally to this work.
Address reprint requests to Stanley J. Korsmeyer, MD, Howard Hughes Medical Institute, Washington University School of Medicine, St Louis, MO 63110.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
REFERENCES |
1.
Thirman MJ,
Gill HJ,
Burnett RC,
Mbangkollo D,
Mccabe NR,
Kobayashi H,
Ziemin-van der Poel S,
Kaneko Y,
Morgan R,
Sandberg AA,
Chaganti RSK,
Larson RA,
Le Beau MM,
Diaz MO,
Rowley JD:
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
N Engl J Med
329:909,
1993[Abstract/Free Full Text]
2.
Chen CS,
Sorensen PHB,
Domer PH,
Reaman GH,
Korsmeyer SJ,
Heerema NA,
Hammond GD,
Kersey JH:
Molecular rearrangements on chromosome-11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome.
Blood
81:2386,
1993[Abstract/Free Full Text]
3.
Poirel H,
Rack K,
Delabesse E,
Radford-Weiss R,
Troussard X,
Debert C,
Leboneu D,
Bastard C,
Picard F,
Veil-Bozyn A,
Flandrin G,
Bernard O,
Macintyre E:
Incidence and characterization of Mll gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
Blood
87:2496,
1996[Abstract/Free Full Text]
4.
Mazo A,
Huang D,
Mozer BA,
Dawid IB:
The trithorax gene, a trans-acting regulator of the bithorax complex in Drosphila, encodes a protein with zinc-binding domains.
Proc Natl Acad Sci USA
87:2112,
1990[Abstract/Free Full Text]
5.
Gu Y,
Nakamura T,
Alder H,
Prasad R,
Canaani O,
Cimino G,
Croce BM,
Canaani E:
The t(4; 11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF4 gene.
Cell
71:701,
1992[Medline]
[Order article via Infotrieve]
6.
Tkachuk DC,
Kohler S,
Cleary ML:
Involvement of a homolog of Drosophila-trithorax by 11q23 chromosomal translocations in acute leukemias.
Cell
71:691,
1992[Medline]
[Order article via Infotrieve]
7.
Domer PH,
Fakharzadeh SS,
Chen CS,
Jockel J,
Johansen L,
Silverman GA,
Kersey JH,
Korsmeyer SJ:
Acute mixed lineage leukemia t(4; 11)(q21; q23) generates an MLL-AF4 fusion product.
Proc Natl Acad Sci USA
90:7884,
1993[Abstract/Free Full Text]
8.
Breen TR,
Harte PJ:
trithorax regulates multiple homeotic genes in the bithorax and Antennapedia complexes and exerts different tissue-specific, parasegment-specific and promoter-specific effects on each.
Development
117:119,
1993[Abstract/Free Full Text]
9.
Sedkov YS,
Tillib L,
Mizrokhi L,
Mazo A:
The bithorax complex is regulated by trithorax earlier during Drosophila embryogenesis than is the Antennapedia complex, correlating with a bithorax-like expression pattern of distinct early trithorax transcripts.
Development
120:1907,
1994[Abstract]
10.
Lawrence HJ,
Largman C:
Homebox genes in normal hematopoiesis and leukemia.
Blood
80:2445,
1992[Free Full Text]
11.
Sauvageau G,
Lansdorp PM,
Eaves CJ,
Hogge DE,
Dragowska WH,
Reid DS,
Largman C,
Lawrence HJ:
Differential expression of homeobox genes in functionally distinct CD34+ populations of human bone marrow cells.
Proc Natl Acad Sci USA
91:12223,
1994[Abstract/Free Full Text]
12.
Shen W-F,
Detmer K,
Mathews CHE,
Hack FM,
Morgan DA,
Largman C,
Lawrence HJ:
Modulation of homeobox gene expression alters the phenotype of human hematopoietic cell lines.
EMBO J
11:983,
1992[Medline]
[Order article via Infotrieve]
13.
Nakamura T,
Largaespada DA,
Shaughnessy JD Jr,
Jenkins NA,
Copland NG:
Cooperative activation of Hoxa and Pbxl-related genes in murine myeloid leukemias.
Nat Genet
12:149,
1996[Medline]
[Order article via Infotrieve]
14.
Nakamura T,
Largaespada DA,
Lee MP,
Johnson LA,
Ohyashiki K,
Toyama K,
Chen SJ,
Willman CL,
Chen I-M,
Feinberg AP,
Jenkins NA,
Copeland NG,
Shaughnessy Jr JD:
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7; 11)(p15; p15) in human myeloid leukaemia.
Nat Genet
12:154,
1996[Medline]
[Order article via Infotrieve]
15.
Borrow J,
Shearman AM,
Stanton Jr. VP,
Becher R,
Collins T,
Williams AJ,
Dube I,
Katz F,
Kwong YL,
Morris C,
Ohyashiki K,
Toyama K,
Rowley J,
Housman DE:
The t(7; 11)(p15; p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.
Nat Genet
12:159,
1996[Medline]
[Order article via Infotrieve]
16.
Yu BD,
Hess JL,
Horning SE,
Brown GAJ,
Korsmeyer SJK:
Altered Hox expression and segmental identity in Mll-mutant mice.
Nature
378:505,
1995[Medline]
[Order article via Infotrieve]
17.
LeMouellic H,
Lallemand Y,
Brulet P:
Homeosis in the mouse induced by a null mutation in the HOX3.1 gene.
Cell
69:251,
1992[Medline]
[Order article via Infotrieve]
18. Eaves C, Lambie K: Atlas of Human Hematopoietic Colonies. Vancouver, B.C., Canada, Stem Cell Technologies, 1995
19.
Melotti P,
Ku D-H,
Calabretta B:
Regulation of expression of the hematopoietic stem cell antigen CD34: role of c-myb.
J Exp Med
179:1023,
1994[Abstract/Free Full Text]
20.
Brown J,
Greaves MF,
Molgaard HV:
The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in hematopoietic progenitor cell lines, brain, and embryonic fibroblasts.
Int Immunol
3:175,
1991[Abstract/Free Full Text]
21.
Weiss MJ,
Keller G,
Orkin S:
Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 -/- embryonic stem cells.
Genes Dev
8:1184,
1994[Abstract/Free Full Text]
22.
Olson MC,
Scott EW,
Hack AA,
Su GH,
Tenen DG,
Singh H,
Simon MC:
Pu.l is not essential for early myeloid gene expression but is required for terminal myeloid differentiation.
Immunity
3:703,
1995[Medline]
[Order article via Infotrieve]
23.
McClanahan T,
Dalrymple S,
Barkett M,
Lee F:
Hematopoietic growth receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells.
Blood
81:2903,
1993[Abstract/Free Full Text]
24.
Nishioka Y,
Leder P:
The complete sequence of a chromosomal mouse globin gene reveals elements conserved throughout vertebrate evolution.
Cell
18:875,
1979[Medline]
[Order article via Infotrieve]
25.
Montgomery RA,
Dallman MJ:
Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction.
J Immunol
147:554,
1991[Abstract]
26.
Wong PMC,
Chung SW,
Shui DHK,
Eaves CJ:
Properties of the earliest clonogenic hemopoietic precursors to appear in the developing murine yolk sac.
Proc Natl Acad Sci USA
83:3851,
1986[Abstract/Free Full Text]
27.
Corral J,
Lavenir I,
Impey H,
Warren AJ,
Forster A,
Larson TA,
Bell S,
McKenzie ANJ,
King G,
Rabbitts TH:
An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes.
Cell
85:853,
1996[Medline]
[Order article via Infotrieve]
28.
Fidanza V,
Melotti P,
Yano T,
Nakamura T,
Bradley A,
Canaani E,
Calabretta B,
Croce CM:
Double knockout of the ALL-1 gene blocks hematopoietic differentiation in vitro.
Cancer Res
56:1179,
1996[Abstract/Free Full Text]
29.
Keller G,
Kennedy M,
Papayannopoulou T,
Wiles MV:
Hematopoietic commitment during embryonic stem cell differentiation in culture.
Mol Cell Biol
13:473,
1993[Abstract/Free Full Text]
30.
Metcalf D,
Nicola NA:
Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: Effects of combination with colony-stimulating factors.
Proc Natl Acad Sci USA
88:6239,
1991[Abstract/Free Full Text]
31.
Civin CI,
Strauss LC,
Brovall C,
Fackler MJ,
Schwartz JF,
Shaper JH:
Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.
J Immunol
133:157,
1984[Abstract]
32.
Broudy VC,
Lin N,
Zsebo KM,
Birkett NC,
Smith KA,
Bernstein ID,
Papayannopoulou T:
Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor.
Blood
79:338,
1992[Abstract/Free Full Text]
33.
Gunji Y,
Nakamura M,
Osawa H,
Nagayoshi K,
Nakauchi H,
Miura Y,
Yanagisawa M,
Suda T:
Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells.
Blood
82:3283,
1993[Abstract/Free Full Text]
34.
Simmons PJ,
Aylett GW,
Niutta S,
To LB,
Juttner CA,
Ashman LK:
c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Exp Hematol
22:157,
1994[Medline]
[Order article via Infotrieve]
35.
Briddel RA,
Broudy VC,
Bruno E,
Brandt JE,
Srour EF,
Hoffman R:
Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor.
Blood
79:3159,
1992[Abstract/Free Full Text]
36.
Sudo T,
Nishikawa S,
Ogawa M,
Kataoka H,
Ohno N,
Izawa A,
Hayashi S-I,
Nishikawa S-I:
Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M.
Oncogene
11:2469,
1995[Medline]
[Order article via Infotrieve]
37.
Orkin SH:
Transcription factors and hematopoietic development.
J Biol Chem
270:4955,
1995[Free Full Text]
38.
Shivdasani RA,
Orkin SH:
The transcriptional control of hematopoiesis.
Blood
87:4025,
1996[Free Full Text]
39.
Shivdasani RA,
Mayer EL,
Orkin SH:
Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL.
Nature
373:432,
1995[Medline]
[Order article via Infotrieve]
40.
Robb L,
Lyons I,
Li R,
Hartley L,
Kontgen F,
Harvey RP,
Metcalf D,
Begley CG:
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Proc Natl Acad Sci USA
92:7075,
1995[Abstract/Free Full Text]
41.
Porcher C,
Swat W,
Rockell K,
Fujiwara Y,
Alt FW,
Orkin SH:
The T cell leukemia oncogene SCL/tal-1 is essential for development of all hematopoietic lineages.
Cell
86:47,
1996[Medline]
[Order article via Infotrieve]
42.
Warren AJ,
Colledge WH,
Carlton WH,
Carlton MBL,
Evans MJ,
Smith AJH,
Rabbits TH:
The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development.
Cell
78:45,
1994[Medline]
[Order article via Infotrieve]
43.
Tsai F-Y,
Keller G,
Kuo FC,
Weiss MJ,
Chen J-Z,
Rosenblatt M,
Alt F,
Orkin SH:
An early haematopoietic defect in mice lacking the transcription factor GATA-2.
Nature
371:221,
1994[Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. Popovic, L. E. Riesbeck, C. S. Velu, A. Chaubey, J. Zhang, N. J. Achille, F. E. Erfurth, K. Eaton, J. Lu, H. L. Grimes, et al.
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization
Blood,
April 2, 2009;
113(14):
3314 - 3322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Maillard, Y.-X. Chen, A. Friedman, Y. Yang, A. T. Tubbs, O. Shestova, W. S. Pear, and X. Hua
Menin regulates the function of hematopoietic stem cells and lymphoid progenitors
Blood,
February 19, 2009;
113(8):
1661 - 1669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, J. Wong, M. Klinger, M. T. Tran, K. M. Shannon, and N. Killeen
Mll5 contributes to hematopoietic stem cell fitness and homeostasis
Blood,
February 12, 2009;
113(7):
1455 - 1463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Sun, C. T. Kong, F. P. Huang, and L. C. Chan
Aberrant dendritic cell differentiation initiated by the Mll-Een fusion gene does not require leukemic transformation
J. Leukoc. Biol.,
January 1, 2008;
83(1):
173 - 180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Liu, E. H.-Y. Cheng, and J. J.-D. Hsieh
Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions
Genes & Dev.,
October 1, 2007;
21(19):
2385 - 2398.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten
Dietary flavonoids induce MLL translocations in primary human CD34+ cells
Carcinogenesis,
August 1, 2007;
28(8):
1703 - 1709.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ueda, R. Watanabe-Fukunaga, H. Ogawa, H. Fukuyama, Y. Higashi, S. Nagata, and R. Fukunaga
Critical role of the p400/mDomino chromatin-remodeling ATPase in embryonic hematopoiesis
Genes Cells,
May 1, 2007;
12(5):
581 - 592.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Maetens, G. Doumont, S. D. Clercq, S. Francoz, P. Froment, E. Bellefroid, U. Klingmuller, G. Lozano, and J.-C. Marine
Distinct roles of Mdm2 and Mdm4 in red cell production
Blood,
March 15, 2007;
109(6):
2630 - 2633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Diehl, L. Rossig, A. M. Zeiher, S. Dimmeler, and C. Urbich
The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation
Blood,
February 15, 2007;
109(4):
1472 - 1478.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Wang, C. C. Shupenko, L. F. Melo, and P. R. Strauss
DNA Repair Protein Involved in Heart and Blood Development
Mol. Cell. Biol.,
December 1, 2006;
26(23):
9083 - 9093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Santillan, C. M. Theisler, A. S. Ryan, R. Popovic, T. Stuart, M.-M. Zhou, S. Alkan, and N. J. Zeleznik-Le
Bromodomain and Histone Acetyltransferase Domain Specificities Control Mixed Lineage Leukemia Phenotype.
Cancer Res.,
October 15, 2006;
66(20):
10032 - 10039.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Glaser, J. Schaft, S. Lubitz, K. Vintersten, F. van der Hoeven, K. R. Tufteland, R. Aasland, K. Anastassiadis, S.-L. Ang, and A. F. Stewart
Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development
Development,
April 15, 2006;
133(8):
1423 - 1432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-X. Chen, J. Yan, K. Keeshan, A. T. Tubbs, H. Wang, A. Silva, E. J. Brown, J. L. Hess, W. S. Pear, and X. Hua
The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression
PNAS,
January 24, 2006;
103(4):
1018 - 1023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Horton, D. G. Grier, G. J. McGonigle, A. Thompson, M. Morrow, I. De Silva, D. A. Moulding, D. Kioussis, T. R.J. Lappin, H. J.M. Brady, et al.
Continuous MLL-ENL Expression Is Necessary to Establish a "Hox Code" and Maintain Immortalization of Hematopoietic Progenitor Cells
Cancer Res.,
October 15, 2005;
65(20):
9245 - 9252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Milne, Y. Dou, M. E. Martin, H. W. Brock, R. G. Roeder, and J. L. Hess
From The Cover: MLL associates specifically with a subset of transcriptionally active target genes
PNAS,
October 11, 2005;
102(41):
14765 - 14770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Armstrong and A. T. Look
Molecular Genetics of Acute Lymphoblastic Leukemia
J. Clin. Oncol.,
September 10, 2005;
23(26):
6306 - 6315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Libura, D. J. Slater, C. A. Felix, and C. Richardson
Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
Blood,
March 1, 2005;
105(5):
2124 - 2131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Daser and T. H. Rabbitts
Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis
Genes & Dev.,
May 1, 2004;
18(9):
965 - 974.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. B. Zeisig, T. Milne, M.-P. Garcia-Cuellar, S. Schreiner, M.-E. Martin, U. Fuchs, A. Borkhardt, S. K. Chanda, J. Walker, R. Soden, et al.
Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization
Mol. Cell. Biol.,
January 15, 2004;
24(2):
617 - 628.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Cozzio, E. Passegue, P. M. Ayton, H. Karsunky, M. L. Cleary, and I. L. Weissman
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors
Genes & Dev.,
December 15, 2003;
17(24):
3029 - 3035.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Ayton and M. L. Cleary
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
Genes & Dev.,
September 15, 2003;
17(18):
2298 - 2307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Yokoyama, I. Kitabayashi, P. M. Ayton, M. L. Cleary, and M. Ohki
Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties
Blood,
November 15, 2002;
100(10):
3710 - 3718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Collins, A. Appert, L. Ariza-McNaughton, R. Pannell, Y. Yamada, and T. H. Rabbitts
Mouse Af9 Is a Controller of Embryo Patterning, Like Mll, Whose Human Homologue Fuses with AF9 after Chromosomal Translocation in Leukemia
Mol. Cell. Biol.,
October 15, 2002;
22(20):
7313 - 7324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. Owens and R. G. Hawley
HOX and Non-HOX Homeobox Genes in Leukemic Hematopoiesis
Stem Cells,
September 1, 2002;
20(5):
364 - 379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. DiMartino, P. M. Ayton, E. H. Chen, C. C. Naftzger, B. D. Young, and M. L. Cleary
The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10
Blood,
May 15, 2002;
99(10):
3780 - 3785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. B. Zraly, Y. Feng, and A. K. Dingwall
Genetic and Molecular Analysis of Region 88E9;88F2 in Drosophila melanogaster, Including the ear Gene Related to Human Factors Involved in Lineage-Specific Leukemias
Genetics,
March 1, 2002;
160(3):
1051 - 1065.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Schreiner, M. Birke, M.-P. Garcia-Cuellar, O. Zilles, J. Greil, and R. K. Slany
MLL-ENL Causes a Reversible and myc-dependent Block of Myelomonocytic Cell Differentiation
Cancer Res.,
September 1, 2001;
61(17):
6480 - 6486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yamada, M. Abe, T. Higashi, H. Yamamoto, F. Kihara-Negishi, T. Sakurai, T. Shirai, and T. Oikawa
Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells
Blood,
April 15, 2001;
97(8):
2300 - 2307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-j. Xu, S. Matsuoka, F.-C. Yang, Y. Ebihara, A. Manabe, R. Tanaka, M. Eguchi, S. Asano, T. Nakahata, and K. Tsuji
Evidence for the presence of murine primitive megakarycytopoiesis in the early yolk sac
Blood,
April 1, 2001;
97(7):
2016 - 2022.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Johnstone, M. Gerber, T. Landewe, A. Tollefson, W. S. Wold, and A. Shilatifard
Functional Analysis of the Leukemia Protein ELL: Evidence for a Role in the Regulation of Cell Growth and Survival
Mol. Cell. Biol.,
March 1, 2001;
21(5):
1672 - 1681.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. D. Car and V. M. Eng
Special Considerations in the Evaluation of the Hematology and Hemostasis of Mutant Mice
Vet. Pathol.,
January 1, 2001;
38(1):
20 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sano, A. Hayakawa, J.-H. Piao, Y. Kosaka, and H. Nakamura
Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23)
Blood,
February 1, 2000;
95(3):
1066 - 1068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. T. Adler, R. Chinery, D. Y. Wu, S. J. Kussick, J. M. Payne, A. J. Fornace Jr., and D. C. Tkachuk
Leukemic HRX Fusion Proteins Inhibit GADD34-Induced Apoptosis and Associate with the GADD34 and hSNF5/INI1 Proteins
Mol. Cell. Biol.,
October 1, 1999;
19(10):
7050 - 7060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Felix and B. J. Lange
Leukemia in Infants
Oncologist,
June 1, 1999;
4(3):
225 - 240.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Osaka, J. D. Rowley, and N. J. Zeleznik-Le
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25)
PNAS,
May 25, 1999;
96(11):
6428 - 6433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Yu, R. D. Hanson, J. L. Hess, S. E. Horning, and S. J. Korsmeyer
MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis
PNAS,
September 1, 1998;
95(18):
10632 - 10636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. De Vivo, X. Cui, J. Domen, and M. L. Cleary
Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1
PNAS,
August 4, 1998;
95(16):
9471 - 9476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Yagi, K. Deguchi, A. Aono, Y. Tani, T. Kishimoto, and T. Komori
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Blood,
July 1, 1998;
92(1):
108 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Caslini, A. Shilatifard, L. Yang, and J. L. Hess
The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation
PNAS,
March 14, 2000;
97(6):
2797 - 2802.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Abstract
Introduction
Abstract